Eggo, Rosalind M

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2021) · Science

COVID-19 epidemiological studiesSARS-CoV-2 and COVID-19 Research

Cited by 2,581

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2020) · Science

COVID-19 epidemiological studiesSARS-CoV-2 and COVID-19 Research

Cited by 2,557

Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts

Hellewell, J., Abbott, S., Gimma, A., Bosse, N. I., Jarvis, C. I., Russell, T. W., Munday, J. D., Kucharski, A. J., Edmunds, W. J., Sun, F., et al. (2020) · The Lancet Global Health

COVID-19 epidemiological studiesMathematical and Theoretical Epidemiology and Ecology Models

Cited by 2,550

Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study

Kucharski, A. J., Klepac, P., Conlan, A. J. K., Kissler, S. M., Tang, M. L., Fry, H., Gog, J. R., Edmunds, W. J., Emery, J. C., Medley, G., et al. (2020) · The Lancet Infectious Diseases

COVID-19 epidemiological studiesCOVID-19 Digital Contact Tracing

Cited by 900

Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study

Davies, N. G., Kucharski, A. J., Eggo, R. M., Gimma, A., Edmunds, W. J., Jombart, T., O'Reilly, K., Endo, A., Hellewell, J., Nightingale, E. S., et al. (2020) · The Lancet Public Health

COVID-19 epidemiological studiesCOVID-19 Prevention and Impact

Cited by 848

Secondary attack rate and superspreading events for SARS-CoV-2

Liu, Y., Eggo, R. M., & Kucharski, A. J. (2020) · The Lancet

COVID-19 epidemiological studiesSARS-CoV-2 and COVID-19 Research

Cited by 350

Effectiveness of airport screening at detecting travellers infected with novel coronavirus (2019-nCoV)

Quilty, B. J., Clifford, S., group2, C. N. W., Flasche, S., & Eggo, R. M. (2020) · Eurosurveillance

COVID-19 epidemiological studiesTravel-related health issues

Cited by 321

Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February

Grint, D. J., Wing, K., Williamson, E., McDonald, H. I., Bhaskaran, K., Evans, D., Evans, S. J., Walker, A. J., Hickman, G., Nightingale, E., et al. (2021) · Eurosurveillance

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 189

Behavioral change towards reduced intensity physical activity is disproportionately prevalent among adults with serious health issues or Self-Perception of high risk during the UK COVID-19 Lockdown

Rogers, N. T., Waterlow, N. R., Brindle, H., Enria, L., Eggo, R. M., Lees, S., & Roberts, C. H. (2020) · Frontiers in Public Health

Physical Activity and HealthCOVID-19 and Mental Health

Cited by 140

Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform

Nab, L., Parker, E. P. K., Andrews, C. D., Hulme, W. J., Fisher, L., Morley, J., Mehrkar, A., MacKenna, B., Inglesby, P., Morton, C. E., et al. (2023) · The Lancet Public Health

COVID-19 Clinical Research StudiesCOVID-19 epidemiological studies

Cited by 97

Modelling the medium-term dynamics of SARS-CoV-2 transmission in England in the Omicron era

Barnard, R. C., Davies, N. G., Centre for Mathematical Modelling of Infectious Diseases COVID-19 working group, Munday, J. D., Lowe, R., Knight, G. M., Leclerc, Q. J., Tully, D. C., Hodgson, D., Pung, R., et al. (2022) · Nature Communications

COVID-19 epidemiological studiesSARS-CoV-2 and COVID-19 Research

Cited by 68

Safety of COVID-19 vaccination and acute neurological events: a self-controlled case series in England using the OpenSAFELY platform

Walker, J. L., Schultze, A., Tazare, J., Tamborska, A., Singh, B., Donegan, K., Stowe, J., Morton, C. E., Hulme, W. J., Curtis, H. J., et al. (2022) · Vaccine

SARS-CoV-2 and COVID-19 ResearchPharmacovigilance and Adverse Drug Reactions

Cited by 30